Cyclerion Therapeutics, Inc.
-
Ticker
CYCN
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Cambridge, Massachusetts
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of sGC pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Lead programs include its vascular-targeted olinciguat in Phase 2 development for sickle cell disease and IW-6463, a pioneering CNS-penetrant sGC stimulator in clinical development for
…More Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like episodes (MELAS) and Alzheimer's Disease with Vascular pathology (ADv)
Cyclerion Therapeutics, Inc.
Most Recent Annual Report
MOST RECENT
2021 Annual Report and Form 10K
Older/Archived Annual Reports